{"id":"NCT03435081","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-02-20","primaryCompletion":"2019-12-09","completion":"2021-08-16","firstPosted":"2018-02-15","resultsPosted":"2021-01-25","lastUpdate":"2022-09-09"},"enrollment":440,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Atopic Dermatitis"],"interventions":[{"type":"DRUG","name":"Baricitinib","otherNames":["LY3009104"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"2 milligram (mg) Baricitinib","type":"EXPERIMENTAL"},{"label":"1 mg Baricitinib","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis.","primaryOutcome":{"measure":"Percentage of Participants Achieving Eczema Area and Severity Index 75 (EASI75) (2 mg Baricitinib)","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo","deltaMin":8.2,"sd":null},{"arm":"2 mg Baricitinib","deltaMin":29.5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":81,"countries":["United States","Canada","Puerto Rico"]},"refs":{"pmids":["36749121","35442530","35086348","34846636","34688290","33826132"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/1Wc7bHopCgKYI4SqseaaSI"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":146},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Diarrhoea","Urinary tract infection","Asthma"]}}